drugset / Trial / NCT06477952
DRonabinol Treatment of OSA
Phase 1/2
Recruiting
120 enrolled
VA Office of Research and Development
University of Illinois at Chicago · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label trial that tests the effectiveness of Dronabinol in treating obstructive sleep apnea (OSA). All participants will take oral Dronabinol for two weeks. Sleep studies will be conducted before and after treatment to measure OSA severity.
Timeline
- Start
- 2025-08-25
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | — | Oral |